Alterity Therapeutics Limited (PBN) - Total Liabilities

Latest as of December 2025: €2.65 Million EUR ≈ $3.10 Million USD

Based on the latest financial reports, Alterity Therapeutics Limited (PBN) has total liabilities worth €2.65 Million EUR (≈ $3.10 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Alterity Therapeutics Limited - Total Liabilities Trend (2014–2025)

This chart illustrates how Alterity Therapeutics Limited's total liabilities have evolved over time, based on quarterly financial data. See Alterity Therapeutics Limited working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

Alterity Therapeutics Limited Competitors by Total Liabilities

The table below lists competitors of Alterity Therapeutics Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Victek Co. Ltd KQ:065450	Korea	₩65.87 Billion
Huikwang TWO:6508	Taiwan	NT$412.10 Million
abrdn Asia Pacific Income Fund VCC TO:FAP	Canada	CA$47.58 Million
Seosan Corporation KQ:079650	Korea	₩5.50 Billion
Futebol Clube do Porto - Futebol S.A.D. LS:FCP	Portugal	€547.94 Million
Sparebank 68 Grader Nord OL:SB68	Norway	Nkr11.17 Billion
DY Corporation KO:013570	Korea	₩448.43 Billion
Finetek Co. Ltd KQ:131760	Korea	₩57.35 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Alterity Therapeutics Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Alterity Therapeutics Limited market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	21.98	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Alterity Therapeutics Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Alterity Therapeutics Limited (2014–2025)

The table below shows the annual total liabilities of Alterity Therapeutics Limited from 2014 to 2025.

Year	Total Liabilities	Change
2025-06-30	€3.62 Million ≈ $4.24 Million	-33.22%
2024-06-30	€5.43 Million ≈ $6.34 Million	+20.44%
2023-06-30	€4.50 Million ≈ $5.27 Million	-23.57%
2022-06-30	€5.89 Million ≈ $6.89 Million	+89.20%
2021-06-30	€3.12 Million ≈ $3.64 Million	+13.00%
2020-06-30	€2.76 Million ≈ $3.22 Million	-17.83%
2019-06-30	€3.36 Million ≈ $3.92 Million	+26.86%
2018-06-30	€2.64 Million ≈ $3.09 Million	+66.25%
2017-06-30	€1.59 Million ≈ $1.86 Million	-32.53%
2016-06-30	€2.36 Million ≈ $2.76 Million	-13.35%
2015-06-30	€2.72 Million ≈ $3.18 Million	-31.19%
2014-06-30	€3.95 Million ≈ $4.62 Million	--

About Alterity Therapeutics Limited

F:PBN Germany Biotechnology

Market Cap

$4.37 Billion

€3.74 Billion EUR

Market Cap Rank

#20934 Global

#1893 in Germany

Share Price

€0.34

Change (1 day)

-5.49%

52-Week Range

€0.00 - €0.36

All Time High

€0.36